Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility | Accountability Console
Complaints IAMs Register Login

Loading...

Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility

Sectors

Community capacity and development

Description:

Projects in this Sector: 78

Browse Projects

Other

Description:

Projects in this Sector: 246

Browse Projects

Issues Raised

Unknown

Description:

Projects with this Issue Raised: 637

Browse Projects

Project Information

Investment ID: 4083-SRI

Bank: Asian Development Bank

Environmental Category: B

Country: Sri Lanka

Region: South Asia

Approval Date: July 8, 2021

Investment Types: Loans

Total Project Cost: USD 95.9 million

Total Complaints: 1

Description

The project will provide the Government of Sri Lanka with immediate and flexible financing to support the national COVID-19 vaccination program through APVAX and the regular country allocation. The APVAX allocation comprises a rapid response component (RRC) to support the purchase of Asian Development Bank (ADB) eligible COVID-19 vaccines, while the project investment component (PIC) financed by the regular country allocation will support strengthening of the vaccination information dissemination and monitoring systems, vaccine transportation capacity, and vaccine-related medical waste management.

Investments

Investment Type ID Amount Status Bank Client
Loans 4083-SRI USD 84.0 million Planned ADB